BlackRock Health Sciences Trust (BMEZ) Fair Value 2026

BMEZ · — ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

2.0 /10

32 fundamental signals · 7 models active

Value Trap Risk

— (—/100)

Quick Summary — As of 2026-07-17, BlackRock Health Sciences Trust (BMEZ) trades at $15.23, approximately 267% above CirclFi’s Bayesian DCF fair value of $4.15. QOC: 2.0/10. 7/13 models active.

Key Facts

Ticker
BMEZ
Price
$15.23
Quality Score
2.0/10
Value Trap Risk
—/100
Models Active
7/13
Last Updated
Strength: First Chicago suggests +14.2% upside with 2% confidence
Risk: Below-average Quality Score of 2.0/10 signals weak fundamentals

Is BlackRock Health Sciences Trust (BMEZ) Undervalued or Overvalued in 2026?

According to CirclFi’s 7-model valuation engine, BlackRock Health Sciences Trust (BMEZ) appears overvalued as of : the median of 7 independent fair value estimates is $11.35, 25.4% below the current price of $15.23. Estimates range from $4.15 to $18.53. BMEZ scores 2.0/10 on fundamental quality and —/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy BlackRock Health Sciences Trust Stock in 2026? →

Valuation Matrix

7 Intrinsic Value Models vs. Current Price ($15.23)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $4.15 -72.8%
CUCE Ensemble
Low Conviction
 $11.04 -27.5%
First Chicago
Low Conviction
 $17.39 +14.2%

Unlock the Full Matrix

Access 4 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 7 Models →

Cancel anytime · No contracts · Instant access

What Is BlackRock Health Sciences Trust (BMEZ) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, BlackRock Health Sciences Trust's intrinsic value is estimated at a composite fair value of $12.71. Trading at $15.23, the stock is approaching fair value or slight overvaluation (implied return of -16.5%), as 4 of 7 models suggest limited further upside. Model dispersion is worth noting: Sentiment SOTP targets $18.53 (+21.7%), versus Bayesian DCF at $4.15 (-72.8%). This +94.5% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About BMEZ?

7 of 13 models are currently active for BMEZ. Of these, 2 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates BMEZ's intrinsic value at $4.15, implying -72.8% downside from the current price. See which stocks rank higher →

How Does BMEZ Rank in —?

BMEZ operates in the — sector. CirclFi's QOC score of 2.0/10 evaluates 32 fundamental signals. A score of 2.0 signals below-average fundamentals.

BlackRock Health Sciences Trust operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is BMEZ a Value Trap?

The Value Trap algorithm is not active for BMEZ. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

7 of 13 models are active for BlackRock Health Sciences Trust. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, BlackRock Health Sciences Trust earns a quality score of 2.0/10. This concerning rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +94.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every BMEZ valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across BMEZ's 7 active models, average confidence is 3%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy BlackRock Health Sciences Trust Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar — Stocks Should You Also Analyze?

8 related — stocks with 13-model coverage

PSECProspect Capital CorporationQOC 8.4SCMStellus Capital Investment CorpQOC 7.8FDUSFidus Investment CorporationQOC 7.6HTGCHercules Capital, Inc.QOC 7.6GLADGladstone Capital CorporationQOC 7.4TPVGTriplePoint Venture Growth BDC QOC 7.3OXSQOxford Square Capital Corp.QOC 7.2GBDCGolub Capital BDC, Inc.QOC 7.2

Read investment analysis: PSEC · SCM · FDUS · HTGC · GLAD

Frequently Asked Questions About BlackRock Health Sciences Trust

What is BlackRock Health Sciences Trust's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, BlackRock Health Sciences Trust (BMEZ) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $4.15. The Quality of Company score is 2.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is BMEZ overvalued or undervalued right now?

At $15.23, 2 of 7 active models suggest BMEZ may be undervalued, while 5 indicate potential overvaluation. The median of all 7 fair value estimates is $11.35, 25.4% below the current price of $15.23 — a consensus view that BMEZ is overvalued. The assessment depends on which methodology best fits BlackRock Health Sciences Trust's business model in —.

What does a Quality of Company score of 2.0 mean for BMEZ?

BlackRock Health Sciences Trust's QOC of 2.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on BMEZ?

CirclFi analyzes BMEZ with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 7 of 13 are active for this stock. Read the full methodology →

Is BMEZ a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for BMEZ at this time. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 7-model valuation engine, BlackRock Health Sciences Trust (BMEZ) has a median fair value of $11.35 — 25.4% below the current price of $15.23 — as of 2026-07-17.” Source: circlfi.com/stock/BMEZ/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 7 mathematical frameworks give you clarity on BMEZ.

Unlock All 7 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access